Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) is eyeing second-half sales growth and hopes to launch its hay fever vaccine in Germany by next year. The company also saw strong early data from its peanut allergy treatment and is in talks for extra funding.
Itaconix PLC (AIM:ITX, OTCQB:ITXXF) says it's started 2025 on stronger ground, with higher margins and a better customer mix after ditching low-margin contracts. Sales fell overall last year, but its core business jumped more than 50%, with strong growth in hygiene and beauty.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) posted record results, with profits swinging to $17.9 million and operating cash flow nearly tripling to $42 million. CEO Mark Learmonth says the Bilboes project in Zimbabwe is being refined to boost returns and cut upfront costs.
Adriatic Metals PLC (LSE:ADT1, ASX:ADT, OTCQX:ADMLF) reported its best quarter yet, milling 68,000 tonnes at its Vareš silver mine in Bosnia.
The mine is now cashflow positive, and production is on track to hit full capacity later this year.
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) just secured EU patent approval for its CoalSwitch tech, a cleaner alternative to traditional biomass fuel. The patent clears the way for broader rollout across Europe and supports the company’s push into green energy.
